Results 111 to 120 of about 5,796 (217)

Is Palivizumabe a Protective Factor for the Development of Asthma in Children? A Systematic Review With Metanalysis. [PDF]

Pediatr Pulmonol
Manini MB, da Silva NC, de Castro RA, Grotta MB, Toro AADC.   +4 more
europepmc   +1 more source

Prevalence of Resistance-Associated Mutations in RSV F Protein Against Monoclonal Antibodies Prior to Widespread Implementation: Findings From a Prospective German Pediatric Cohort. [PDF]

Influenza Other Respir Viruses
Wetzke M, Le DB, Tometten I, Ritter S, Lübke N, Timm J, Dilthey A, Panning M, Walker A, Happle C.   +9 more
europepmc   +1 more source

Detection of ON1 and novel genotypes of human respiratory syncytial virus and emergence of palivizumab resistance in Lebanon

, 2019
Hadi Abou‐El‐Hassan, Elie Massaad, Nadia Soudani, Aia Assaf‐Casals, Rouba Shaker, Mireille Lteif Khoury, Soha Ghanem, Maria Karam, Rabih R. Andary, Reiko Saito, Ghassan Dbaibo, Hassan Zaraket   +11 more
openalex   +2 more sources

Effect of delayed palivizumab administration on respiratory syncytial virus infection-related hospitalisation

, 2021
Akiko Kamori, Yuya Morooka, Kenichiro Yamamura, Pin Fee Chong, Noriko Kuga, Yasushi Takahata, Koichi Sagawa, Kenji Furuno   +7 more
openalex   +1 more source

Recommendation for use of a long-acting monoclonal antibody to prevent respiratory syncytial virus infection in infants and young children. [PDF]

Clin Exp Pediatr
Choi SH, Kim DH, Ahn JG, Yun KW, Eun BW, Lee J, Lee J, Lee TJ, Lee H, Jo DS, Cho EY, Cho HK, Choe YJ, Choi UY, Kim YK, Committee on Infectious Diseases of the Korean Pediatric Society.   +15 more
europepmc   +1 more source

Application of the Probability Model for Starting Period to Initiate to Take Palivizumab by Prefecture Using National Official Sentinel Surveillance in Japan

, 2020
Junko Kurita, Tamie Sugawara, Yasushi Ohkusa, Michiko Nohara   +3 more
openalex   +2 more sources

The cost-effectiveness of palivizumab in infants with cystic fibrosis in the Canadian setting: A decision analysis model [PDF]

, 2016
Ashleigh McGirr, Kevin L. Schwartz, Upton Allen, Melinda Solomon, Beate Sander   +4 more
openalex   +1 more source

Improvement in Palivizumab Administration in Severely Immunocompromised Children: A Single-institution Quality Improvement Initiative. [PDF]

Pediatr Qual Saf
Hijano DR, Allen DC, Burlison J, Ross HS, Ferrolino JA, Dallas RH, Hayden RT, Morton TH, Greene WL, Wolf J, Ramilo O, Flynn PM, Cross SJ.   +12 more
europepmc   +1 more source

Cost minimisation of RSV prevention with palivizumab

, 2006
Stacey Wills
openalex   +1 more source

Description of the Outcomes of Prior Authorization of Palivizumab for Prevention of Respiratory Syncytial Virus Infection in a Managed Care Organization [PDF]

, 2010
Brieana C. Buckley, Derek Roylance, Matthew P. Mitchell, Sushma M. Patel, H Eric Cannon, Jeffrey D. Done   +5 more
openalex   +1 more source